Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1998
11/25/1998EP0486562B1 Mutant pseudorabies virus, and vaccines containing the same
11/25/1998CN1200148A Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
11/25/1998CN1200147A Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/25/1998CN1200146A Compounds and methods for diagnosis of tuberculosis
11/25/1998CN1200037A Chicken interleukin-15 and uses thereof
11/24/1998US5840871 Pure polynucleotide sequence as hybridization probes complementary to the polynucleotide; transformed cell cultures yield protein; possible anticancer agents for breast and cell cancer
11/24/1998US5840856 Antibodies to a human PF4 superfamily receptor
11/24/1998US5840855 Mycobacterial recombinants and peptides
11/24/1998US5840854 Monoclonal antibody BR110 and uses thereof
11/24/1998US5840853 Parathyroid hormone receptor and DNA encoding same
11/24/1998US5840847 Purified prostaglandin receptor FP
11/24/1998US5840846 Fibronectin binding protein as well as its preparation
11/24/1998US5840843 Synthetic polypeptides as inhibitors of HIV-1
11/24/1998US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
11/24/1998US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component
11/24/1998US5840700 Methods of producing transfer factor
11/24/1998US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins
11/24/1998US5840693 Vascular endothelial growth factor-B
11/24/1998US5840679 Method of inhibiting P-selectin ligand activity
11/24/1998US5840588 Binding hapten to erythrocyte or latex particles; mixing sample with antibody against hapten, combining antibody with bound hapten; agglutination occurs only when lack of hapten in sample; simplicity, high speed, specificity
11/24/1998US5840574 Nucleotide sequence including coding portion of marek*s disease virus gene
11/24/1998US5840569 Human GTP-binding proteins
11/24/1998US5840565 Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
11/24/1998US5840563 Method for growing swine infertility and respiratory syndrome virus
11/24/1998US5840560 Glucose kinase from streptococcus pneumoniae
11/24/1998US5840556 Molecular genetic construction of vaccine strains of pasteurellaceae
11/24/1998US5840545 Immunoglubulins
11/24/1998US5840541 Recombinant molecule comprising the polyhedrin gene promoter of baculovirus and a structural gene of a rotovirus; biosynthesis of antigenic protein ns28; use in vaccines, viral detection
11/24/1998US5840538 Lgt
11/24/1998US5840535 DNA encoding a zinc ring protein
11/24/1998US5840531 Expression of mammalian islet cell neogenesis associated protein; vectors, probes, antisense constructs
11/24/1998US5840530 DNA encoding receptors for the beta-2 chain of human IL-12
11/24/1998US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis
11/24/1998US5840520 Recombinant negative strand RNA virus expression systems
11/24/1998US5840513 Antibodies directed to pagC peptides for the detection of salmonellae
11/24/1998US5840508 Kit for determining biological antigen comprising detergent having specified structure, modifying reagent, antigen or corresponding antibody
11/24/1998US5840504 Method for separating sex specific molecules and non-sex specific molecules
11/24/1998US5840498 Antibiotic cryptdin peptides and methods of their use
11/24/1998US5840493 Diagnosis of late onset diabetes by detection of mutations in adenosine triphosphate synthase or transfer rna (lys) genes in a biological sample; labelled nucleotide sequences as detectors; accuracy
11/24/1998US5840483 Method of maintaining a desired recombinant gene in a genetic population of cells
11/24/1998US5840480 Retrovirus from the HIV group and its use
11/24/1998US5840344 Monoclonal antibodies having property of causing apoptosis
11/24/1998US5840340 Oligopeptides with fragrance, cosmetics and dye
11/24/1998US5840317 Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen
11/24/1998US5840316 Desensitization
11/24/1998US5840315 Treating or preventing bovine mastitis
11/24/1998US5840314 Production of streptococcal M protein
11/24/1998US5840313 Antigenic peptides induce antibody-dependent cellular cytotoxicity against hiv
11/24/1998US5840312 Recombinant Bacillus anthracis strains unable to produce the lethal factor protein or edema factor protein
11/24/1998US5840306 DNA encoding human papillomavirus type 18
11/24/1998US5840304 Amino acid sequences and codes for t-cells
11/24/1998US5840303 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
11/24/1998US5840302 Treatment of bacterially-induced inflammatory diseases
11/24/1998US5840301 Methods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptors
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998US5840298 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
11/24/1998US5840297 Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process
11/24/1998US5840083 A medical equipment for grafting in mammalian body comprising an amphiphilic coatings having an antibodies receptor molecule conjugated to a supports lipids and membrane protein; ion conductivity
11/24/1998CA2020439C Modified biologically active protein
11/24/1998CA1340140C Human gamma, delta t cell antigen receptor polypetides and nucleic acids
11/24/1998CA1340139C Particle-stabilized epitopes for standardization and control of immunoassays
11/23/1998CA2232810A1 Novel compounds
11/23/1998CA2232809A1 Novel compounds
11/23/1998CA2232808A1 Novel compounds
11/23/1998CA2232807A1 Novel compounds
11/23/1998CA2230996A1 Novel compounds
11/23/1998CA2221837A1 A novel human gene similar to a secreted protein frizb (atg-1639)
11/23/1998CA2221836A1 A novel human gene similar to a secreted murine protein sfrp-1
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/22/1998CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/21/1998CA2232811A1 Novel def1
11/19/1998WO1998051810A1 Lentivirus-based gene transfer vectors
11/19/1998WO1998051796A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998WO1998051793A1 Apo-2 RECEPTOR
11/19/1998WO1998051787A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety
11/19/1998WO1998051706A1 Tumor-associated antigen
11/19/1998WO1998051346A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998WO1998051342A1 Substrates materials with bound cytokine-stimulating polysaccharides or bacterial nucleic acids
11/19/1998WO1998051341A1 ANTIGEN-mPEG CONJUGATES SUPPRESS HUMORAL AND CELL MEDIATED IMMUNE RESPONSES
11/19/1998WO1998051340A1 Fas ligand expressing antigen presenting cells for tolerance induction
11/19/1998WO1998051339A1 Multivalent vaccine composition with mixed carrier
11/19/1998WO1998051338A1 Improved method for administration of vaccine against shigella infections
11/19/1998WO1998051337A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051321A1 Tissue factor for influencing blood vessel formation
11/19/1998WO1998051279A2 Method of making microencapsulated dna for vaccination and gene therapy
11/19/1998WO1998051217A1 Vaccine against lipopolysaccharide core
11/19/1998WO1998037095A3 Recombinant pox virus for immunization against muc1 tumor-associated antigen
11/19/1998WO1998037089A3 Matrix derived anti-hiv peptides and transdominant proteins
11/19/1998WO1998035694A3 A pharmaceutical composition for treating hepatitis b virus (hbv) infection
11/19/1998WO1998034640A3 Synthetic hiv gag genes
11/19/1998CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998CA2290067A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998CA2289760A1 Vaccine against lipopolysaccharide core
11/19/1998CA2288599A1 Tumor-associated antigen
11/19/1998CA2288328A1 Lentivirus-based gene transfer vectors
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998CA2287911A1 Apo-2 receptor
1 ... 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 ... 1823